Western Europe Animal Health Market, By Vaccines

Growth Outlook

• The Western Europe Animal Health Market, By Vaccines market is on a steady long-term growth path. Segment value stands at roughly USD 2363 Mn in 2026 and is projected to reach USD 2547 Mn by 2027 — a gain of about 8% over the forecast period, translating to a CAGR in the high single digits.
• What the regional split looks like (2026): Live Attenuated Vaccines leads, holding roughly 65% of segment value — the single largest regional share. Inactivated Vaccines is the second-largest contributor. Recombinant Vaccines, DNA Vaccines and Others make up the remainder, in descending order.
• By 2027, Live Attenuated Vaccines alone is expected to reach USD 1667 Mn, with Inactivated Vaccines at USD 534 Mn.

Market Dynamics

The animal health market in Western Europe is a dynamic and rapidly growing sector, driven by various factors such as the rising demand for quality animal products, increasing pet ownership, and the growing awareness about animal health and well-being among consumers.

One of the major drivers of the animal health market in Western Europe is the increasing occurrence of infectious diseases among animals. These diseases have a direct impact on animal health, leading to severe economic losses for farmers and other animal owners. In response to this, the demand for vaccines has significantly increased, as they serve as a preventive measure against these diseases.

Vaccines play a crucial role in maintaining the health and well-being of animals, both in the livestock and pet sectors. Vaccines work by stimulating the animal's immune system to produce antibodies that fight against specific diseases. They have been successful in controlling and eliminating various infectious diseases in animals, thus reducing mortality rates and increasing the overall health of animals.

In Western Europe, there is a high demand for vaccines in the livestock sector due to the region's large and advanced agricultural industry. Livestock vaccines help prevent and control diseases such as foot-and-mouth disease, avian influenza, and bovine viral diarrhea, among others. These diseases not only affect the health of animals but also have the potential to spread to humans, making livestock vaccines crucial for both animal and human health.

In the pet sector, the demand for vaccines is mainly driven by the increase in pet ownership in Western Europe. With more people considering their pets as part of the family, there is a growing focus on their health and well-being. This has led to a rise in pet vaccinations as an essential preventive measure to keep them healthy and free from diseases.

Moreover, there is a growing trend of pet owners seeking advanced and specialized vaccines for their pets, such as those for Lyme disease and canine flu. This trend has led to the development of new and innovative vaccines, further driving the growth of the animal health market in Western Europe.

In conclusion, the demand for vaccines in the Western Europe animal health market is rapidly increasing, driven by the need to prevent and control infectious diseases in both livestock and pets. As the region continues to prioritize animal health and well-being, the demand for vaccines is expected to further rise in the coming years, creating new opportunities for market players.